Radiomics study for predicting the expression of PD-L1 in non -small cell lung cancer based on CT images and clinicopathologic features

被引：4
|
作者：
Sun, Zongqiong [1 ,2 ]
Hu, Shudong [2 ]
Ge, Yuxi [2 ]
Wang, Jun [3 ]
Duan, Shaofeng [4 ]
Song, Jiayang [4 ]
Hu, Chunhong [1 ]
Li, Yonggang [1 ]
机构：
[1] Soochow Univ, Affiliated Hosp 1, Dept Radiol, Suzhou 215006, Jiangsu, Peoples R China
[2] Jiangnan Univ, Affiliated Hosp, Dept Radiol, Wuxi, Jiangsu, Peoples R China
[3] Shanghai Univ, Shanghai Inst Adv Commun & Data Sci, Sch Commun & Informat Engn, Shanghai, Peoples R China
[4] Gen Elect GE Healthcare China, Shanghai, Peoples R China
来源：
JOURNAL OF X-RAY SCIENCE AND TECHNOLOGY | 2020年 / 28卷 / 03期
基金：
中国国家自然科学基金;
关键词：
IMMUNOTHERAPY; BIOMARKERS; CHALLENGES; STATISTICS; RISK;
D O I：
暂无
中图分类号：
TH7 [仪器、仪表];
学科分类号：
0804 ; 080401 ; 081102 ;
摘要：
引用
收藏
页码：449 / 459
页数：11
相关论文
共 50 条
  • [41] Targeting the PD-1/PD-L1 axis for the treatment of non-small-cell lung cancer
    Meyers, D. E.
    Bryan, P. M.
    Banerji, S.
    Morris, D. G.
    CURRENT ONCOLOGY, 2018, 25 (04) : E324 - E334
  • [42] PD-L1 expression in cell-blocks of non-small cell lung cancer: The impact of prolonged fixation
    Vigliar, Elena
    Iaccarino, Antonino
    Campione, Severo
    Campanino, Maria R.
    Clery, Eduardo
    Pisapia, Pasquale
    De Luca, Caterina
    Bellevicine, Claudio
    Malapelle, Umberto
    De Dominicis, Gianfranco
    Troncone, Giancarlo
    DIAGNOSTIC CYTOPATHOLOGY, 2020, 48 (07) : 595 - 603
  • [43] Expression of PD-L1 Is Associated with Inflammatory Microenvironment in Surgical Specimens of Non-Small Cell Lung Cancer
    Simundza, Ivan
    Krnic, Dragan
    Juricic, Josko
    Benzon, Benjamin
    Simundza, Rina
    Stanicic, Ivan Mario
    Capkun, Vesna
    Vukojevic, Katarina
    Durdov, Merica Glavina
    JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (08):
  • [44] PD-L1 Expression in Non-Small Cell Lung Cancer: Data from a Referral Center in Spain
    Saez de Gordoa, Karmele
    Lopez, Ingrid
    Marginet, Marta
    Coloma, Berta
    Frigola, Gerard
    Vega, Naiara
    Martinez, Daniel
    Teixido, Cristina
    DIAGNOSTICS, 2021, 11 (08)
  • [45] PD-1/PD-L1 Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
    Bagley, Stephen J.
    Bauml, Joshua M.
    Langer, Corey J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (10) : 676 - 683
  • [46] Molecular regulatory network of PD-1/PD-L1 in non-small cell lung cancer
    Zhu, Lingling
    Lin, Jiewei
    Wang, Li
    Yan, Danli
    Zhou, Jie
    Li, Wen
    Pu, Dan
    Peng, Lei
    Zhou, Qinghua
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (04)
  • [47] Phase II study of atezolizumab with bevacizumab for non-squamous non-small cell lung cancer with high PD-L1 expression (@Be Study)
    Seto, Takashi
    Nosaki, Kaname
    Shimokawa, Mototsugu
    Toyozawa, Ryo
    Sugawara, Shunichi
    Hayashi, Hidetoshi
    Murakami, Haruyasu
    Kato, Terufumi
    Niho, Seiji
    Saka, Hideo
    Oki, Masahide
    Yoshioka, Hiroshige
    Okamoto, Isamu
    Daga, Haruko
    Azuma, Koichi
    Tanaka, Hiroshi
    Nishino, Kazumi
    Tohnai, Rie
    Yamamoto, Nobuyuki
    Nakagawa, Kazuhiko
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (02)
  • [48] Radiomics models based on multisequence MRI for predicting PD-1/PD-L1 expression in hepatocellular carcinoma
    Gong, Xue-Qin
    Liu, Ning
    Tao, Yun-Yun
    Li, Li
    Li, Zu-Mao
    Yang, Lin
    Zhang, Xiao-Ming
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [49] PD-L1 expression and EGFR status in advanced non-small-cell lung cancer patients receiving PD-1/PD-L1 inhibitors: a meta-analysis
    Li, Jing
    Gu, Jian
    FUTURE ONCOLOGY, 2019, 15 (14) : 1667 - 1678
  • [50] Validation of the QR1 Antibody for the Evaluation of PD-L1 Expression in Non-Small Cell Lung Adenocarcinomas
    Brandone, Nicolas
    Mascaux, Celine
    Caselles, Kevin
    Rouquette, Isabelle
    Lantuejoul, Sylvie
    Garcia, Stephane
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2020, 28 (01) : 23 - 29
12345